Jennifer Ciresi
@Redmile Group, Llc
Latest period2024 - Q3ReportedManaged Assets$1.697BTotal holdings63
Assets growth rate2.63%Assets growth rate (2-Q avg)-18.33%Continuous growth in asset value1 quarters
Portfolio positions
This chart displays the top 10 holdings in Redmile Group, Llc's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 63 positions.
Assets under management
The assets under management (AUM) of Redmile Group, Llc over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.697B in assets, with a quarterly growth rate of 2.63% and a 2-quarter average growth rate of -18.33%. The portfolio is managed by Jennifer Ciresi, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
BPMCBlueprint Medicines Corp
| 0% | $10.175M 94,405 shares@ $107.79 avg price | Exited |
TRDAEntrada Therapeutics Inc
| 0% | $7.994M 560,971 shares@ $14.26 avg price | Exited |
LABStandard Biotools Inc
| 0% | $728,587 411,631 shares@ $1.78 avg price | Exited |
HOOKHookipa Pharma Inc
| 0% | $629,538 1.064M shares@ $0.6 avg price | Exited |
TKNOAlpha Teknova Inc
| 0% | $211,677 154,509 shares@ $1.37 avg price | Exited |